Latest Breaking News On - Alyssa watanabe - Page 1 : vimarsana.com

CureMetrix cmAssist by CureMetrix helps radiologists by identifying, marking and scoring regions of interest on screening mammograms Improving sensitivity and specificity, cmAssist AI-CAD acts as a ‘second pair of eyes’ for the radiologist, delivering efficiency and more accurate detection of breast cancer for the women of Brazil.” Alyssa Watanabe, MD, FACR, Chief Medical Officer CureMetrix SAN DIEGO, CA, USA, May 12, 2021 /EINPresswire.com/ CureMetrix, Inc., a global healthcare technology company that develops AI-driven software for radiology, announced it has received approval from Brazil’s Agência Nacional de Vigilância Sanitária (ANVISA) for cmAssist ®, its proprietary AI-based detection software for mammography. This ANVISA registration 81464750084 allows CureMetrix to market cmAssist to radiology practices and hospitals in Brazil.

United statesAlyssa watanabeCuremetrix incChief medical officerNacional de vigilDigital imagingNavid alipourJournal of digital imagingHttps consultas anvisa gov br documentos tecnicos 25351356579202146 253ஒன்றுபட்டது மாநிலங்களில்அலிஸா வாடேநாப்ய்தலைமை மருத்துவ அதிகாரிநேஸீயநல் டி விழிப்புணர்வுடிஜிட்டல் இமேஜிங்